Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(6 sites)
United States
City of Hope Comprehensive Cancer Center, Duarte, California University of Illinois at Chicago, Chicago, Illinois Memorial Sloan Kettering Cancer Center, New York, New York The Ohio state University, Columbus, Ohio University of Pennsylvania / Abramson Cancer Center, Philadelphia, Pennsylvania Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah